Symposia: Thrombotic Microangiopathies/Thrombocytopenias and COVID-19-related Thrombotic/Vascular Disorders: Clinical and Epidemiological
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, epidemiology, Clinical Research, Genetic Disorders, Diseases, thrombocytopenias, thrombotic disorders, registries, survivorship
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, Bleeding and Clotting, epidemiology, Clinical Research, Genetic Disorders, Diseases, thrombocytopenias, thrombotic disorders, registries, survivorship
Monday, December 11, 2023: 10:30 AM-12:00 PM
Room 29
(San Diego Convention Center)
Moderators:
Pavan K Bendapudi, MD, Beth Israel Deaconess Medical Center
and
Radhika Gangaraju, MD, University Of Alabama
Disclosures:
Bendapudi: Takeda Pharmaceuticals: Consultancy; Alexion Pharmaceuticals: Consultancy. Gangaraju: Sanofi Genzyme: Consultancy, Honoraria; Alexion: Consultancy; Takeda: Consultancy.
Oral abstracts in this session discuss population prevalence and recombinant ADAMTS13 for congenital TTP, provide insights into the kinetics of ADAMTS13 recovery in reponse to targeted therapies in immune TTP, and subclinical cardiac disease in immune TTP survivors.
10:30 AM
10:45 AM
11:00 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH